Prosecution Insights
Last updated: October 02, 2026
Application No. 19/065,709

HEMOSTASIS CLIP WITH COLLAPSIBLE CAPSULE

Non-Final OA §112
Filed
Feb 27, 2025
Priority
May 28, 2019 — provisional 62/853,303 +3 more
Examiner
GABR, MOHAMED GAMIL
Art Unit
Tech Center
Assignee
Boston Scientific Corporation
OA Round
1 (Non-Final)
80%
Grant Probability
Favorable
1-2
OA Rounds
1y 3m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 80% — above average
80%
Career Allowance Rate
434 granted / 539 resolved
+20.5% vs TC avg
Strong +22% interview lift
Without
With
+21.9%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
33 currently pending
Career history
569
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
43.4%
+3.4% vs TC avg
§102
27.5%
-12.5% vs TC avg
§112
20.0%
-20.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 539 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment In response to the amendment filed on 02/27/2025, Claims 1-35 have been cancelled, and newly added Claims 36-51 are pending. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 36-52 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding Claim 36, the limitation “a cap slidably coupled to and projecting distally from the capsule so that, when engaging features of the clip arms abut against the cap as the clip arms are drawn proximally into the capsule via the cap, the cap is moved proximally along the capsule.” Renders the claim indefinite because its unclear if Applicant is reciting that the cap projects distally from the capsule when the engaging features of the clip arms are abutted against the cap when the clip arms are drawn proximally via the cap by moving the cap proximally against the capsule or if Applicant is attempting to claim another configuration. A review of the specification appears to have support for “the engaging features 144 extend from a portion of the clip arms 104 so that, when the clip arms 104 are drawn proximally relative to the capsule 106, the engaging features 144 abut a portion of a distal face 146 of the cap 114. The engaging features 144 are positioned along the clip arms 104 so that, when the engaging features 144 engage the cap 114, the clip arms 104 are drawn toward the closed configuration.” (Paragraph 0035 of PGPub). The examiner notes here that the capsule (106) of the disclosure includes both a longitudinal body (112) and a cap (114), but Claim 1 currently recites the cap as a separate structure from the capsule. Its not clear from the images or the disclosure that the clip arms are drawn into the longitudinal body (112; Paragraph 0031) and not in the capsule as claimed, since the capsule as claimed is being interpreted as the longitudinal body. Claims 37-48 are rejected for incorporating errors from the parent claim by dependency. Regarding Claim 49, the limitation “the engaging feature abuts against the cap moving the cap proximally along the capsule to reduce a length of the capsule” renders the claim indefinite because it is unclear how the capsule, as claimed, can reduce its length. Paragraph 0031 of the instant specification pgpub states that the capsule (106) includes the longitudinal body and the cap, and in this context the capsule can change its length. However, the way Claim 49 is constructed, the cap is a separate structure and its unclear how the capsule (longitudinal body) can reduce its length. Claims 51-52 are rejected for incorporating errors from their parent claim by dependency. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: Kimura (US PGPub 2005/0143767) Sugiyama (US Patent 6,991,634) Shibata (US Patent 8,062,310) Adams (US Patent 8,440,660) Durgin (US PGPub 2016/0262748) Randhawa (US PGPub 2018/0140300) Tsueda (US Patent 10,441,292) Any inquiry concerning this communication or earlier communications from the examiner should be directed to MOHAMED GAMIL GABR whose telephone number is (571)272-0569. The examiner can normally be reached M-F 9am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jackie Ho can be reached at (571) 270-5953. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MOHAMED G GABR/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Feb 27, 2025
Application Filed
Sep 10, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12745999
DEVICES AND METHODS OF VISUALIZING AND DETERMINING DEPTH OF PENETRATION IN CARDIAC TISSUE
2y 0m to grant Granted Sep 29, 2026
Patent 12740841
COMPUTER-ASSISTED TELEOPERATED SURGERY SYSTEMS AND METHODS
2y 9m to grant Granted Sep 22, 2026
Patent 12740796
Grasper and Repository for Removal of Multiple Kidney Stone Fragments
2y 9m to grant Granted Sep 22, 2026
Patent 12733923
CANNULA WITH SUTURE LOCK
2y 1m to grant Granted Sep 15, 2026
Patent 12727906
ENDOSCOPIC SURGICAL TOOL
2y 0m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
80%
Grant Probability
99%
With Interview (+21.9%)
2y 10m (~1y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 539 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month